Clinical Applications of Immunotherapy for Recurrent Glioblastoma in Adults

Clinical Applications of Immunotherapy for Recurrent Glioblastoma in Adults

Glioblastoma (GBM) is the most common malignant primary brain tumor in adults. Despite standard therapies, including resection and chemoradiation, recurrence is virtually inevitable. Current treatment for recurrent glioblastoma (rGBM) is rapidly evolving, and emerging therapies aimed at targeting pr...

Full description

Bibliographic Details
Main Authors: Meagan Mandabach Olivet, Michael C. Brown, Zachary J. Reitman, David M. Ashley, Gerald A. Grant, Yuanfan Yang, James M. Markert
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Cancers
Subjects:
recurrent glioblastoma
rGBM
immunotherapy
checkpoint inhibitor
vaccine
oncolytic virus
Online Access:https://www.mdpi.com/2072-6694/15/15/3901

Similar Items

Similar Items